J0517 Injection., benralizumab, 1 milligrams
J-Codes
Also known as: benralizumab, Fasenra
Benralizumab injection, 1 milligram, a monoclonal antibody that targets interleukin-5 for treatment of severe eosinophilic asthma.
Clinical Context
Indicated for moderate to severe eosinophilic asthma in patients inadequately controlled on inhaled corticosteroids. Administered subcutaneously every 4 weeks for 3 doses, then every 8 weeks.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.